Jeil Pharmaceutical Co.,Ltd (KRX:271980)

Market Cap	220.76B
Revenue (ttm)	661.60B
Net Income (ttm)	5.16B
Shares Out	14.57M
EPS (ttm)	354.28
PE Ratio	42.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,428
Average Volume	118,190
Open	15,380
Previous Close	15,250
Day's Range	15,050 - 15,410
52-Week Range	10,120 - 16,750
Beta	0.85
RSI	61.55
Earnings Date	Nov 14, 2025

About KRX:271980

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 947
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 271980